1474058-89-3 Usage
Description
2-methyl-2-(4-vinylphenoxy)propionic acid, also known as 2-(4-Ethenylphenoxy)-2-methyl-propanoic Acid, is an organic compound that is identified as an impurity in Ciprofibrate, a hypolipemic agent. It is structurally related to Clofibrate and possesses a unique chemical structure with a vinyl group attached to a phenoxy moiety, which may contribute to its potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
2-methyl-2-(4-vinylphenoxy)propionic acid is used as an impurity in the production of Ciprofibrate, which serves as an antilipemic agent. Its presence, although as an impurity, may have implications for the overall efficacy and safety profile of the drug, making it a relevant compound to study and understand in the context of hypolipidemic therapy.
Additionally, given its unique chemical structure, 2-methyl-2-(4-vinylphenoxy)propionic acid could potentially be explored for other applications within the pharmaceutical industry, such as in the development of new drugs or drug delivery systems, due to its vinyl group which may allow for further chemical modifications and interactions with biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 1474058-89-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,7,4,0,5 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1474058-89:
(9*1)+(8*4)+(7*7)+(6*4)+(5*0)+(4*5)+(3*8)+(2*8)+(1*9)=183
183 % 10 = 3
So 1474058-89-3 is a valid CAS Registry Number.
1474058-89-3Relevant articles and documents
Discovery of (E)-4-styrylphenoxy-propanamide: A dual PPARα/γ partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice
Dutra, Luiz A.,Lacerda, Mariella G.,Destro Inácio, Maiara,Martins, Johnny W.L.,Lopes Silva, Ana C.,Bento da Silva, Patricia,Chorilli, Marlus,Amato, Angélica A.,Baviera, Amanda M.,Passarelli, Marisa,Guido, Rafael V.C.,Dos Santos, Jean L.
, (2022/01/26)
Peroxisome proliferator-activated receptors are promising therapeutic targets for metabolic diseases, including obesity, diabetes, and dyslipidemia. This study describes the design, synthesis and pharmacological evaluation of stilbene-based compounds as d
